[PRNewswire] AGC Biologics Appoints David Stewart as the New General Manager/
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Site Head of the Boulder, Colorado Site
(BOULDER, Colo., Jan. 21, 2021 PRNewswire=연합뉴스) AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production at its Boulder, Colorado site. Effective February 1, 2021, David Stewart will join the Boulder team as the General Manager/Site Head.
Mr. Stewart brings a servant leader mindset, with a proven record of delivering best-in-class supply for client organizations and the patients they serve. He promotes accountability, innovation, collaboration, and agility to build high-performance teams. He also brings more than 20 years of leadership experience in the biotechnology and manufacturing industry, including roles with Biogen and Genentech. In his new role, Mr. Stewart will support the continuous growth of the Site, while partnering closely with colleagues across AGC Biologics' global network of facilities to bring new biopharmaceuticals to market.
"We are very happy that Mr. Stewart is joining us as General Manager/Site Head for the Boulder Site. He brings broad experience and demonstrated leadership ability from large-scale biologics drug substance operations," said AGC Biologics Chief Technical Officer, Kasper Møller. "I am confident that Mr. Stewart will lead the Boulder Site to successful operations in support of our customers' growing demands."
About AGC Biologics:
AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to deliver the highest standard of service as we work side-by-side with our clients and partners, every step of the way. We provide world-class development and manufacture of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), viral vectors and genetically engineered cells. Our global network spans the U.S., Europe and Asia, with cGMP-compliant facilities in Seattle, Washington; Boulder, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba, Japan and we currently employ more than 1,600 employees worldwide. Our commitment to continuous innovation fosters the technical creativity to solve our clients' most complex challenges, including specialization in fast-track projects and rare diseases. AGC Biologics is the partner of choice. To learn more, visit www.agcbio.com.
Logo - https://mma.prnewswire.com/media/624983/AGC_Biologics_logo_Logo.jpg
Source: AGC Biologics
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
Copyright © 연합뉴스 보도자료. 무단전재 및 재배포 금지.
- 의대교수 사직 D-1…'찻잔속 태풍' 불과 vs "실제로 사직할 것" | 연합뉴스
- '약자 복지' 강조한 尹대통령, 이재명과 '약자만 선별지원' 논의하나 | 연합뉴스
- 與 "입법 독재" 野 "총선 민심"…5월 국회 앞두고 정면 대치(종합) | 연합뉴스
- 임무명 'B·T·S'…국산 초소형 군집위성 1호 발사 성공 | 연합뉴스
- 카드사들, K-패스 출시…버스·지하철·GTX타면 최소 20% 환급(종합) | 연합뉴스
- 연금개혁안 놓고 갑론을박…"재투표해야" vs "민주주의 훼손"(종합) | 연합뉴스
- "전자담배 기술발명 보상 못받아" KT&G 前연구원 2조8천억 소송(종합) | 연합뉴스
- 尹, 與낙선자들 만나 "제 부족함 깊이 성찰하고 있다"(종합2보) | 연합뉴스
- 野위성정당 서미화·김윤 당선인, 민주 합류…민주당 171석으로 | 연합뉴스
- 초대 우주청장에 윤영빈…임무본부장 NASA 출신 존 리(종합) | 연합뉴스